Companies · Biotechnology

Agri-Neo Inc

TORONTO · Biotechnology

Diligence memoA one-page analyst read on Agri-Neo Inc — recommendation, valuation, rhythm, risks.
$491K
Total raised · real
3
Rounds
1.1×
Latest step-up
Top 91%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Thu Jul 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Agri-Neo Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.50× the median modeled value of Pre-Seed Biotechnology companies in 2016–2018 (152 peers) — value vs value, same stage and era.
Dormant
  • Last raise 9.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

Agri-Neo Inc is one of 4291 Biotechnology companies tracked from TORONTO. By capital raised it ranks in the long tail (ahead of 10% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
5
Investors (latest)
2017-07-13
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MPre-Seed · 2015-08-14 Raised $119K (real) Modeled valuation $6.5M (est)$119K$6.5MPre-Seed2015Pre-Seed · 2015-10-31 Raised $180K (real) Modeled valuation $9.9M (est)$180K$9.9MPre-Seed2015Pre-Seed · 2015-10-31 Raised $180K (real) Modeled valuation $9.9M (est)$180K$9.9MPre-Seed2015Pre-Seed · 2017-07-13 Raised $193K (real) Modeled valuation $11M (est)$193K$11MPre-Seed2017+$180K+$180K+$193KCumulative $671K

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$119K · 2015
Pre-Seed extension$180K · 2015
Pre-Seed extension$180K · 2015
Pre-Seed extension$193K · 2017

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$10.7M
Base estimate est.
$103K
Conservative case
$120.8M
Upside case
$1.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $6.5M · 2015-08-142015Pre-Seed · modeled $9.9M · 2015-10-31Pre-Seed · modeled $9.9M · 2015-10-31Pre-Seed · modeled $10.7M · 2017-07-132017
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
24%
Survival probability
10% low · 44% high
1.86×/yr
Annual markup
2.52×/yr upside case
6.0 yr
Elapsed time used
9.0 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
8 mo
Avg between rounds
$257K/yr
Capital velocity
10.9 yr
On record since
2015
First round
4
Rounds on file
How it compares to the market

Benchmarked against 4291 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.1× of median
This company$491K
Sector median$7.2M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 0.5× of median
This company$193K
Sector median$412K
Modeled value — vs sector median (estimate, all stages) 0.2× of median
This company$10.7M
Sector median$64.2M

Raised more than 10% of sector peers (real $). Modeled value above 19% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #118 of 152.

This companyCohort peer
$1.0M$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Cerebral Magnetics INC · Pre-Seed Raised $1.0M · modeled $55.2M (est)AnTolRx, Inc. · Pre-Seed Raised $1.0M · modeled $55.2M (est)NutriBand Inc. · Pre-Seed Raised $1.2M · modeled $55.2M (est)US Biologic, Inc. · Pre-Seed Raised $1.0M · modeled $55.2M (est)New Vital Signs, Inc. · Pre-Seed Raised $1.0M · modeled $55.2M (est)Jivana Biotechnology Inc · Pre-Seed Raised $2.0M · modeled $55.2M (est)Zeta Biolongevity, Inc. · Pre-Seed Raised $995K · modeled $54.9M (est)ALRGN Bio, Inc. · Pre-Seed Raised $946K · modeled $52.2M (est)BioSurfaces, LLC · Pre-Seed Raised $900K · modeled $49.7M (est)Cellsolutions Llc · Pre-Seed Raised $1.9M · modeled $49.7M (est)Pique Therapeutics, Inc. · Pre-Seed Raised $1.4M · modeled $47.2M (est)NeuExCell Therapeutics Inc. · Pre-Seed Raised $850K · modeled $46.9M (est)Agri-Neo Inc (this company) Raised $491K · modeled $10.7M (est)Agri-Neo Inc
CompanyStageRaised · realValue · estvs peer med.
Cerebral Magnetics INCPre-Seed$1.0M$55.2M2.61×
AnTolRx, Inc.Pre-Seed$1.0M$55.2M2.61×
NutriBand Inc.Pre-Seed$1.2M$55.2M2.61×
US Biologic, Inc.Pre-Seed$1.0M$55.2M2.61×
New Vital Signs, Inc.Pre-Seed$1.0M$55.2M2.61×
Jivana Biotechnology IncPre-Seed$2.0M$55.2M2.61×
Zeta Biolongevity, Inc.Pre-Seed$995K$54.9M2.60×
ALRGN Bio, Inc.Pre-Seed$946K$52.2M2.47×
BioSurfaces, LLCPre-Seed$900K$49.7M2.35×
Cellsolutions LlcPre-Seed$1.9M$49.7M2.35×
Pique Therapeutics, Inc.Pre-Seed$1.4M$47.2M2.23×
NeuExCell Therapeutics Inc.Pre-Seed$850K$46.9M2.22×
Agri-Neo Inc this companyPre-Seed$491K$10.7M0.50×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$119K2015-08-14$658K$6.5M85%
Pre-Seed$180K2015-10-31$998K$9.9M85%
Pre-Seed$180K2015-10-31$998K$9.9M85%
Pre-Seed$193K2017-07-13$1.1M$10.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$119K2015-08-14
    • First recorded raise — entered as Pre-Seed.
    • 4 investors on this round.
  2. Pre-Seed$180K2015-10-31
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • 2 investors on this round.
  3. Pre-Seed$180K2015-10-31
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 2 investors on this round.
  4. Pre-Seed$193K2017-07-13
    • Raised 20 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 5 investors on this round.
Intelligence
2018 ~Q1
Modeled next raise · ~8mo cadence
$207K
Modeled next size est.range $193K$332K
1.1×
Last step-up
$257K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Brian Kim7 other2017-07
Robert Wong1 other2015-08
Fadi David Dagher2015-08
Joseph C. Dillon2015-08
Katheryn David Croll2015-08
Neal Neil Lee2017-07
Nicholas Dillon2015-08
Paul David Simcox2015-08
Rocco David Piccolo2015-08
Warren Libby2015-08
Wiliam Neil Murdoch2017-07
William Neil Murdoch2015-08
Registry & provenance

Agri-Neo Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1636689
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Girihlet Inc.BiotechnologyPre-Seed$500K$9.8Msame sector · same stage
Prisma Imaging, Inc.BiotechnologyPre-Seed$500K$11.0Msame sector · same stage
Eleusis Holdings LtdBiotechnologyPre-Seed$465K$9.3Msame sector · same stage
RevOpsis Therapeutics CorpBiotechnologyPre-Seed$521K$9.9Msame sector · same stage
Scythian Biosciences Inc.BiotechnologyPre-Seed$462K$9.4Msame sector · same stage
149 Medical, Inc.BiotechnologyPre-Seed$450K$8.7Msame sector · same stage
Artimplant ABBiotechnologyPre-Seed$540K$12.8Msame sector · same stage
Theragene Pharmaceuticals, Inc.BiotechnologyPre-Seed$548K$11.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
NEO Farmaceuticals LLCAgricultureSeed$42.6M89%
Neotx Holdings Ltd.BiotechnologySeries C$906.6M88%
AGI Scientific, LLCBiotechnologySeries A$100.2M86%
AgriMetis, LLCBiotechnologySeries B$392.1M85%
BioCurie, Inc.BiotechnologyPre-Seed$1.3M84%
Agilis Biotherapeutics, Inc.BiotechnologySeries A$458.0M84%
Novai LtdBiotechnologySeed$12.0M84%
Project Samri Inc.BiotechnologySeries A$76.4M84%
Frequently asked
How much funding has Agri-Neo Inc raised?
Agri-Neo Inc has raised approximately $491K in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Agri-Neo Inc's estimated valuation?
Provath's modeled valuation for Agri-Neo Inc is approximately $10.7M (modeled range $103K–$120.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Agri-Neo Inc at?
Agri-Neo Inc's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Thu Jul 13.
What does Agri-Neo Inc do and where is it based?
Agri-Neo Inc operates in the Biotechnology sector, based in TORONTO.
Explore related

See where Agri-Neo Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Agri-Neo Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.